KR102012380B1 - 골재생 또는 골형성 촉진용 펩타이드 및 그 용도 - Google Patents

골재생 또는 골형성 촉진용 펩타이드 및 그 용도 Download PDF

Info

Publication number
KR102012380B1
KR102012380B1 KR1020170108652A KR20170108652A KR102012380B1 KR 102012380 B1 KR102012380 B1 KR 102012380B1 KR 1020170108652 A KR1020170108652 A KR 1020170108652A KR 20170108652 A KR20170108652 A KR 20170108652A KR 102012380 B1 KR102012380 B1 KR 102012380B1
Authority
KR
South Korea
Prior art keywords
bone
seq
peptide
artificial
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020170108652A
Other languages
English (en)
Korean (ko)
Other versions
KR20180023874A (ko
Inventor
윤원준
Original Assignee
(주)세원생명공학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)세원생명공학 filed Critical (주)세원생명공학
Publication of KR20180023874A publication Critical patent/KR20180023874A/ko
Application granted granted Critical
Publication of KR102012380B1 publication Critical patent/KR102012380B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020170108652A 2016-08-26 2017-08-28 골재생 또는 골형성 촉진용 펩타이드 및 그 용도 Expired - Fee Related KR102012380B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160109232 2016-08-26
KR20160109232 2016-08-26

Publications (2)

Publication Number Publication Date
KR20180023874A KR20180023874A (ko) 2018-03-07
KR102012380B1 true KR102012380B1 (ko) 2019-08-20

Family

ID=61245095

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170108652A Expired - Fee Related KR102012380B1 (ko) 2016-08-26 2017-08-28 골재생 또는 골형성 촉진용 펩타이드 및 그 용도

Country Status (6)

Country Link
US (1) US20230181677A1 (enExample)
EP (1) EP3505529A4 (enExample)
JP (1) JP6998068B2 (enExample)
KR (1) KR102012380B1 (enExample)
CN (1) CN109863163B (enExample)
WO (1) WO2018038582A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110013566B (zh) * 2019-05-24 2021-09-14 大连医科大学附属第一医院 一种复合骨修复材料的制备方法
CN117462650B (zh) * 2023-10-08 2024-09-24 南京中医药大学 一种多肽a在促进骨再生或骨修复中的用途
PL448149A1 (pl) * 2024-03-29 2025-10-06 Uniwersytet Gdański Peptyd o działaniu osteogennym oraz jego zastosowanie

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US6184205B1 (en) * 1994-07-22 2001-02-06 University Of North Carolina At Chapel Hill GRB2 SH3 binding peptides and methods of isolating and using same
JP3906924B2 (ja) 2003-02-28 2007-04-18 独立行政法人農業生物資源研究所 絹タンパクから細胞生育ペプチドの抽出と利用
KR101013999B1 (ko) * 2004-03-19 2011-02-14 재단법인서울대학교산학협력재단 표면에 골조직 형성 증진 펩타이드가 고정된 차폐막 및임플란트
US20100291593A1 (en) 2007-07-13 2010-11-18 Powell William C Method of identifying diagnostic reagents
EP2268301B1 (en) * 2008-01-24 2020-02-26 Remedor Biomed Ltd. Erythropoietin and fibronectin compositions for bone regeneration
KR100879704B1 (ko) * 2008-06-11 2009-01-22 오스템임플란트 주식회사 골유착 및 골형성을 증진시키는 올리고펩타이드
JP4722207B2 (ja) * 2009-08-06 2011-07-13 株式会社椿本チエイン ケーブル類保護案内装置
CN103509108B (zh) * 2013-08-07 2015-02-25 浙江大学 利用特征十二多肽制备家蚕丝素蛋白特异抗体的方法
CN103665142A (zh) * 2013-11-20 2014-03-26 北京博恩康生物科技有限公司 一种诱导成骨短肽及其制备方法和用途
KR101637497B1 (ko) * 2014-12-19 2016-07-07 (주)케어젠 골형성 펩타이드 및 이의 용도
KR101794401B1 (ko) * 2015-03-26 2017-11-06 윤원준 접착성 펩타이드 및 그 용도

Also Published As

Publication number Publication date
JP6998068B2 (ja) 2022-01-18
CN109863163A (zh) 2019-06-07
US20230181677A1 (en) 2023-06-15
EP3505529A4 (en) 2020-05-13
WO2018038582A1 (ko) 2018-03-01
CN109863163B (zh) 2023-07-21
KR20180023874A (ko) 2018-03-07
JP2019534241A (ja) 2019-11-28
EP3505529A1 (en) 2019-07-03

Similar Documents

Publication Publication Date Title
EP3419678B1 (en) Trizonal membranes for periosteum regeneration
KR101018050B1 (ko) 골형성촉진용 합성펩타이드 ｂｆｐ1, 상기 합성 펩타이드 ｂｆｐ1을 포함하는 골형성촉진기능성 약학조성물 및 배지조성물
KR20050010778A (ko) 결합조직 자극 펩티드
KR102437057B1 (ko) 이식편 이식 및 조직 공학 절차에 있어서의 ｆｇｆ－１８
JPH09505305A (ja) 骨形成促進生成物および骨形成方法
US11596712B2 (en) Autologous bone graft substitute composition
DK3107592T3 (en) Implant Comprehensive FGF-18
KR102012380B1 (ko) 골재생 또는 골형성 촉진용 펩타이드 및 그 용도
Tao et al. Combined treatment with parathyroid hormone (1–34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model
TW200800250A (en) Protein formulation for promoting hard tissue formation
Zhang et al. Advancing collagen-based biomaterials for oral and craniofacial tissue regeneration
Lin et al. Augmentation of osseous phenotypes in vivo with a synthetic peptide
US10836795B2 (en) Dual functional novel peptide having cell permeability and bone tissue regeneration ability, and use thereof
KR101736280B1 (ko) 관절염 예방 또는 치료용 약학적 조성물
Lin et al. Augmentation of demineralized bone matrix (DBM) mineralization by a synthetic growth factor mimetic
US20110111032A1 (en) Manufacturing method of collagen gel composition for bone regeneration
Shao et al. OIC-A006-loaded true bone ceramic heals rabbit critical-sized segmental radial defect
HK40026125A (en) Trizonal membranes for periosteum regeneration
JP2024046128A (ja) 骨形成促進剤
Tansık Bioactive Peptide Nanofibers for Bone Tissue Regeneration
HK1234669A1 (en) Bone formation promoter
Cheng Injectable High Viscosity Liquid Carriers for Bone Tissue Engineering
HK40013257A (en) Dual functional novel peptide having cell permeability and bone tissue regeneration ability, and use thereof
Pina et al. 3.2 Osteoconductive properties of brushite-forming Zn-and ZnSr-substituted β-TCP bone cements

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20240814

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20240814